Federal Register Final rule: FDA is amending the regulation that established conditions under which over-the-counter ophthalmic drug products are generally recognized as safe and effective and not misbranded. This amendment updates the monograph to incorporate a USP name change for hydroxypropyl methylcellulose to hypromellose. To view this notice, click here.
